Atopic dermatitis (AD), a persistent form of eczema, is not always easy to manage, and may impact your quality of life in many different ways. This can make it difficult for you and your doctor or nurse to understand if your AD is under control. ADCT can help.
Measure the impact of AD
across many areas of your life
Assess AD control
in under 1 minute
Assist conversations with your
doctor or nurse about your AD
No language selected
Atopic Dermatitis Control Tool (ADCT) has been scientifically validated to assess atopic dermatitis control status in adult and adolescent patients (12 years and older). To use ADCT correctly, a patient must answer all six ADCT questions by selecting the most appropriate answer. Patients should use ADCT in their own language.
ADCT was developed to facilitate patient-physician discussion on control of atopic dermatitis. ADCT is not intended to replace the physician’s medical judgment in diagnosing and treating the patient.
The user acknowledges and accepts that they are not entitled to amend, modify, condense, adapt, reorganise the tool on any medium whatsoever, in any way whatsoever, even minor, without Sanofi Genzyme’s and Regeneron’s prior specific written consent.
Users must ensure that ADCT is used in the context and with the standards it has been designed and validated for.
If you are planning to use ADCT in a clinical study, please use the following link to request the correct version of ADCT and the copyright from MAPI Research Trust: https://eprovide.mapi-trust.org/instruments/atopic-dermatitis-control-tool
You will be asked to complete a request form describing the intended use of the tool. The information provided with this form helps to ensure that ADCT is used in the context and with the standards it has been designed and validated for.
